CAMBRIDGE, Mass., Feb. 14, 2011 /PRNewswire/ -- Idenix
Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will
report its financial results for the fourth quarter and year end of
2010 on Monday, February 28, 2011
after U.S. financial markets close.
Idenix management will host a conference call at 4:30 p.m. ET on Monday,
February 28, 2011 to discuss the company's financial results
for the fourth quarter and year end of 2010 and provide an update
on the company's development programs.
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter
passcode 44647149 or to listen to a live webcast go to "Calendar of
Events" in the Idenix Investor Center at www.idenix.com. A replay
of the call will also be available from February 28, 2011, 6:30
p.m. ET until March 14, 2011,
11:59 p.m. ET. To access the
replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter
passcode 44647149. An archived webcast will also be available for
two weeks after the call on the Idenix website.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of patients with chronic
hepatitis C infection. For further information about Idenix, please
refer to http://www.idenix.com.
Idenix Pharmaceuticals
Contacts:
|
|
Kelly Barry (617) 995-9033
(media)
|
|
Eric Hoffman (617) 224-4485
(investors)
|
|
|
SOURCE Idenix Pharmaceuticals, Inc.